id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0283-0004,FDA,FDA-2002-E-0283,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA; Correction,Notice,Correction,2005-11-07T05:00:00Z,2005,11,,,2025-09-30T18:16:40Z,05-22012,0,0,090000648049eaa1
FDA-2002-E-0283-0003,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2005-10-26T04:00:00Z,2005,10,,,2025-09-30T18:12:54Z,,0,0,090000648049ea9f